175 related articles for article (PubMed ID: 29327456)
41. Identification of Corosolic and Oleanolic Acids as Molecules Antagonizing the Human RORγT Nuclear Receptor Using the Calculated Fingerprints of the Molecular Similarity.
Pastwińska J; Karaś K; Sałkowska A; Karwaciak I; Chałaśkiewicz K; Wojtczak BA; Bachorz RA; Ratajewski M
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163824
[TBL] [Abstract][Full Text] [Related]
42. Antrodia cinnamomea Extract Inhibits Th17 Cell Differentiation and Ameliorates Imiquimod-Induced Psoriasiform Skin Inflammation.
Li MH; Wu HC; Yao HJ; Lin CC; Wen SF; Pan IH
Am J Chin Med; 2015; 43(7):1401-17. PubMed ID: 26477794
[TBL] [Abstract][Full Text] [Related]
43. Discovery of carbazole carboxamides as novel RORγt inverse agonists.
Huang Y; Yu M; Sun N; Tang T; Yu F; Song X; Xie Q; Fu W; Shao L; Wang Y
Eur J Med Chem; 2018 Mar; 148():465-476. PubMed ID: 29477887
[TBL] [Abstract][Full Text] [Related]
44. Sterol metabolism controls T(H)17 differentiation by generating endogenous RORγ agonists.
Hu X; Wang Y; Hao LY; Liu X; Lesch CA; Sanchez BM; Wendling JM; Morgan RW; Aicher TD; Carter LL; Toogood PL; Glick GD
Nat Chem Biol; 2015 Feb; 11(2):141-7. PubMed ID: 25558972
[TBL] [Abstract][Full Text] [Related]
45. Ternary crystal structure of human RORγ ligand-binding-domain, an inhibitor and corepressor peptide provides a new insight into corepressor interaction.
Noguchi M; Nomura A; Doi S; Yamaguchi K; Hirata K; Shiozaki M; Maeda K; Hirashima S; Kotoku M; Yamaguchi T; Katsuda Y; Crowe P; Tao H; Thacher S; Adachi T
Sci Rep; 2018 Nov; 8(1):17374. PubMed ID: 30478402
[TBL] [Abstract][Full Text] [Related]
46. Imiquimod-induced psoriasis-like skin inflammation is suppressed by BET bromodomain inhibitor in mice through RORC/IL-17A pathway modulation.
Nadeem A; Al-Harbi NO; Al-Harbi MM; El-Sherbeeny AM; Ahmad SF; Siddiqui N; Ansari MA; Zoheir KM; Attia SM; Al-Hosaini KA; Al-Sharary SD
Pharmacol Res; 2015 Sep; 99():248-57. PubMed ID: 26149470
[TBL] [Abstract][Full Text] [Related]
47. Ginseng-derived panaxadiol ameliorates STZ-induced type 1 diabetes through inhibiting RORγ/IL-17A axis.
Tian SY; Chen SM; Feng YY; He JL; Li Y
Acta Pharmacol Sin; 2023 Jun; 44(6):1217-1226. PubMed ID: 36650291
[TBL] [Abstract][Full Text] [Related]
48. Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonists.
Fauber BP; Gobbi A; Savy P; Burton B; Deng Y; Everett C; La H; Johnson AR; Lockey P; Norman M; Wong H
Bioorg Med Chem Lett; 2015 Oct; 25(19):4109-13. PubMed ID: 26321361
[TBL] [Abstract][Full Text] [Related]
49. Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new RORγ inhibitors using virtual screening, synthesis and biological evaluation.
Zhang Y; Xue X; Jin X; Song Y; Li J; Luo X; Song M; Yan W; Song H; Xu Y
Eur J Med Chem; 2014 May; 78():431-41. PubMed ID: 24704616
[TBL] [Abstract][Full Text] [Related]
50. Oral administration of a novel RORγt antagonist attenuates psoriasis-like skin lesion of two independent mouse models through neutralization of IL-17.
Takaishi M; Ishizaki M; Suzuki K; Isobe T; Shimozato T; Sano S
J Dermatol Sci; 2017 Jan; 85(1):12-19. PubMed ID: 27726924
[TBL] [Abstract][Full Text] [Related]
51. Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-γ (RORγ or RORc).
Fauber BP; Magnuson S
J Med Chem; 2014 Jul; 57(14):5871-92. PubMed ID: 24502334
[TBL] [Abstract][Full Text] [Related]
52. Design, Synthesis, and Biological Evaluation of Retinoic Acid-Related Orphan Receptor γt (RORγt) Agonist Structure-Based Functionality Switching Approach from In House RORγt Inverse Agonist to RORγt Agonist.
Yukawa T; Nara Y; Kono M; Sato A; Oda T; Takagi T; Sato T; Banno Y; Taya N; Imada T; Shiokawa Z; Negoro N; Kawamoto T; Koyama R; Uchiyama N; Skene R; Hoffman I; Chen CH; Sang B; Snell G; Katsuyama R; Yamamoto S; Shirai J
J Med Chem; 2019 Feb; 62(3):1167-1179. PubMed ID: 30652849
[TBL] [Abstract][Full Text] [Related]
53. Cholesterol Unbound RORγt Protein Enables a Sensitive Inverse Agonist Screening.
Koyama R; Fukuda Y; Kamada Y; Nakagawa H; Witmer D; Ambrus-Aikelin G; Sang BC; Nakayama M; Iwata H
Assay Drug Dev Technol; 2018; 16(4):194-204. PubMed ID: 29874096
[TBL] [Abstract][Full Text] [Related]
54. Discovery of novel quinoline sulphonamide derivatives as potent, selective and orally active RORγ inverse agonists.
Amaudrut J; Argiriadi MA; Barth M; Breinlinger EC; Bressac D; Broqua P; Calderwood DJ; Chatar M; Cusack KP; Gauld SB; Jacquet S; Kamath RV; Kort ME; Lepais V; Luccarini JM; Masson P; Montalbetti C; Mounier L; Potin D; Poupardin O; Rouaud S; Spitzer L; Wallace CD
Bioorg Med Chem Lett; 2019 Jul; 29(14):1799-1806. PubMed ID: 31101472
[TBL] [Abstract][Full Text] [Related]
55. The cardenolides strophanthidin, digoxigenin and dihydroouabain act as activators of the human RORγ/RORγT receptors.
Karaś K; Sałkowska A; Walczak-Drzewiecka A; Ryba K; Dastych J; Bachorz RA; Ratajewski M
Toxicol Lett; 2018 Oct; 295():314-324. PubMed ID: 29981919
[TBL] [Abstract][Full Text] [Related]
56. Discovery of orally efficacious RORγt inverse agonists. Part 2: Design, synthesis, and biological evaluation of novel tetrahydroisoquinoline derivatives.
Kono M; Oda T; Tawada M; Imada T; Banno Y; Taya N; Kawamoto T; Tokuhara H; Tomata Y; Ishii N; Ochida A; Fukase Y; Yukawa T; Fukumoto S; Watanabe H; Uga K; Shibata A; Nakagawa H; Shirasaki M; Fujitani Y; Yamasaki M; Shirai J; Yamamoto S
Bioorg Med Chem; 2018 Jan; 26(2):470-482. PubMed ID: 29258712
[TBL] [Abstract][Full Text] [Related]
57. Discovery and structural optimization of 4-(4-(benzyloxy)phenyl)-3,4-dihydropyrimidin-2(1H)-ones as RORc inverse agonists.
Wu XS; Wang R; Xing YL; Xue XQ; Zhang Y; Lu YZ; Song Y; Luo XY; Wu C; Zhou YL; Jiang JQ; Xu Y
Acta Pharmacol Sin; 2016 Nov; 37(11):1516-1524. PubMed ID: 27374490
[TBL] [Abstract][Full Text] [Related]
58. Identification and structure activity relationships of quinoline tertiary alcohol modulators of RORγt.
Kummer DA; Cummings MD; Abad M; Barbay J; Castro G; Wolin R; Kreutter KD; Maharoof U; Milligan C; Nishimura R; Pierce J; Schalk-Hihi C; Spurlino J; Urbanski M; Venkatesan H; Wang A; Woods C; Xue X; Edwards JP; Fourie AM; Leonard K
Bioorg Med Chem Lett; 2017 May; 27(9):2047-2057. PubMed ID: 28318945
[TBL] [Abstract][Full Text] [Related]
59. N-Arylsulfonyl Indolines as Retinoic Acid Receptor-Related Orphan Receptor γ (RORγ) Agonists.
Doebelin C; Patouret R; Garcia-Ordonez RD; Chang MR; Dharmarajan V; Kuruvilla DS; Novick SJ; Lin L; Cameron MD; Griffin PR; Kamenecka TM
ChemMedChem; 2016 Dec; 11(23):2607-2620. PubMed ID: 27879053
[TBL] [Abstract][Full Text] [Related]
60. Identification of the first inverse agonist of retinoid-related orphan receptor (ROR) with dual selectivity for RORβ and RORγt.
Gege C; Schlüter T; Hoffmann T
Bioorg Med Chem Lett; 2014 Nov; 24(22):5265-7. PubMed ID: 25305688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]